| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/09/2005 | WO2005083063A1 Cancerous disease modifying antibodies |
| 09/09/2005 | WO2005083062A1 Cell vaccine |
| 09/09/2005 | WO2005083061A1 Stem cell populations and methods of use |
| 09/09/2005 | WO2005083060A1 Human cell strains for protein production, provided by selecting strains with high intracellular protein and mutating with carcinogens |
| 09/09/2005 | WO2005083059A1 Compositions and methods for making insulin-producing cells |
| 09/09/2005 | WO2005083058A1 Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells |
| 09/09/2005 | WO2005083057A1 Magnetic manipulation of biological samples |
| 09/09/2005 | WO2005083056A1 Solid cellulosic culture medium and process for producing the same |
| 09/09/2005 | WO2005082932A2 Compositions and methods using rna interference for control of nematodes in plants |
| 09/09/2005 | WO2005082077A2 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 09/09/2005 | WO2005082002A2 Systems and methods for screening for modulators of neural differentiation |
| 09/09/2005 | WO2005081982A2 Methods for preparing t-cells for cell therapy |
| 09/09/2005 | WO2005081870A2 Intervertebral disc repair, methods and devices therefor |
| 09/09/2005 | WO2005081857A2 Systems and methods for screening for modulators of neural differentiation |
| 09/09/2005 | WO2005081721A2 Method for enhancing transport of semiconductor nanocrystals across biological membranes |
| 09/09/2005 | WO2005056765A3 Methods for culturing keratinocytes from human embryonic stem cells |
| 09/09/2005 | WO2005046614A3 System for treating and preventing breast cancer |
| 09/09/2005 | WO2005035742A3 Methods of preparing and using stem cell compositions and kits comprising the same |
| 09/09/2005 | WO2005035721A3 Native immunoglobulin binding reagents and methods for making and using same |
| 09/09/2005 | WO2005028619A3 Nanoliter-scale synthesis of arrayed biomaterials and screening thereof |
| 09/09/2005 | WO2005003332A3 Diamagnetically stabilised three-dimensional cell culture |
| 09/09/2005 | WO2005000198A3 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 09/09/2005 | WO2004113513A3 Methods and compositions for modulating stem cell growth and differentiation |
| 09/09/2005 | WO2004007683A3 Cellular reprogramming in peptide hydrogel and uses thereof |
| 09/09/2005 | WO2003057854A3 Novel proteins and nucleic acids encoding same |
| 09/09/2005 | CA2799245A1 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 09/09/2005 | CA2558726A1 Method for producing unsaturated omega-3 fatty acids in transgenic organisms |
| 09/09/2005 | CA2557499A1 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 09/09/2005 | CA2557093A1 Cancerous disease modifying antibodies |
| 09/09/2005 | CA2557091A1 Cancerous disease modifying antibodies |
| 09/09/2005 | CA2556018A1 Stem cell populations and methods of use |
| 09/09/2005 | CA2555714A1 Methods for preparing t-cells for cell therapy |
| 09/09/2005 | CA2555230A1 Systems and methods for clonal expression in plants |
| 09/09/2005 | CA2554238A1 Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells |
| 09/09/2005 | CA2552351A1 Method for determination and quantification of radiation or genotoxin exposure |
| 09/09/2005 | CA2550151A1 Method for enhancing transport of semiconductor nanocrystals across biological membranes |
| 09/09/2005 | CA2546853A1 Use of interfering rna in the production of transgenic animals |
| 09/09/2005 | CA2497087A1 Novel genes encoding proteins involved in proanthocyanidin synthesis |
| 09/08/2005 | US20050198713 Methods for developing conifer somatic embryos |
| 09/08/2005 | US20050198711 Indeterminate gametophyte 1 (ig1), mutations of ig1, orthologs of ig1, and uses thereof |
| 09/08/2005 | US20050198702 Expression vector comprising tissue specific regulatory sequences for generating transgenic plants with enhanced phytohormone, carbohydrate and fatty acid metabolism and/or biosynthesis |
| 09/08/2005 | US20050198700 Transchromosomic avian for use as bioreactor for expression of heterologous gene sequences |
| 09/08/2005 | US20050198697 Transgenic mollusk and method for producing the same |
| 09/08/2005 | US20050197497 Used to improve the therapeutic efficacy of current cancer treatment; sensitizing cancerous cells to treatment with conventional anti-tumor drugs |
| 09/08/2005 | US20050197494 Methods of treating thrombotic diseases with von willebrand factor specific antibodies |
| 09/08/2005 | US20050197311 Vector comprising first polynucleotide encoding glucose responsive mRNA instability element, second polynucleotide encoding reporter polypeptide and promoter sequence; fluorescence based high throughput screening |
| 09/08/2005 | US20050197295 Modified annexin proteins and methods for preventing thrombosis |
| 09/08/2005 | US20050196865 Using chinese hamster ovaries as bioreactors for propagation of heterologous gene sequences |
| 09/08/2005 | US20050196864 Propagating transgenic nervous system tissue for use as tools in treatment of parkinson's disease |
| 09/08/2005 | US20050196861 Physiologically active peptides |
| 09/08/2005 | US20050196860 Novel EPS8 compounds for therapy and diagnosis and methods for using same |
| 09/08/2005 | US20050196859 Propagation and/or derivation of embryonic stem cells |
| 09/08/2005 | US20050196858 Isolation, selection and propagation of animal transgenic stem cells |
| 09/08/2005 | US20050196844 Antibodies to phosphorylated tau, methods of making and methods of use |
| 09/08/2005 | US20050196843 genetic replication and recovery of cells having gene expression for antihemophilic and von wilierbrand factor activity, in serum- and protein-free cultures comprising soybean peptones |
| 09/08/2005 | US20050196838 Reduced immunogenicity; increased affinity and avidity; improved cell culturing |
| 09/08/2005 | US20050196837 DNA construct comprising centromeric, telomeric and genomic regions for use in transfer of heterologous sequences into cells |
| 09/08/2005 | US20050196833 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
| 09/08/2005 | US20050196832 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/08/2005 | US20050196829 identifying polymorphisms in gene sequences coding Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A); identifying modulator for prevention and treatment of allergic disorders |
| 09/08/2005 | US20050196828 Bioreactor with expandable surface area for culturing cells |
| 09/08/2005 | US20050196806 Prostate specific antigen oligoepitope peptide |
| 09/08/2005 | US20050196802 peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily; use drug screening |
| 09/08/2005 | US20050196797 PI-3-kinase-related kinase polypeptide for use as tool in identifying modulators for prevntion and treatment of cell proliferation disorders |
| 09/08/2005 | US20050196780 Mammalian decapping polypetide for use as in controlling half-life of transcriptional units in in vitro gene expression systems |
| 09/08/2005 | US20050196754 Nucleotide sequences coding modified immunoglobulin for use in immunodiagnostics and therapy |
| 09/08/2005 | US20050196753 Human coactivator-associated arginine methyltransferase 1 (hCARM1) |
| 09/08/2005 | US20050196752 Genomic sequence of the 5-Lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma |
| 09/08/2005 | US20050196423 Novel tissue engineered scaffolds derived from copper capillary alginate gels |
| 09/08/2005 | US20050196397 Factor IX/factor IXa activating antibodies and antibody derivatives |
| 09/08/2005 | US20050196387 Chondrocytes expressing type II collagen; obtained from human cadavers and grown in vitro; injected into degenerative disc through an aperture or incision, closed with suture or biocompatible glue; harvest from hyaline cartilage of nose, ears, trachea, larynx, articular, costal, epiphyseal plate |
| 09/08/2005 | US20050196386 Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses |
| 09/08/2005 | US20050196385 Lymphocytic cells; industrial production of functional cells, pharmaceutical quality, large amounts; blood, plasma, serum from cytapheresis, frozen stock; cultured with synthetic activators phosphohalohydrin, phosphoepoxide, bisphosphonate,cytokine, interlukin; treat infection, parasites, cancer |
| 09/08/2005 | US20050196377 Covalent binding of a hydrogel to an extracellular matrix; primed extracellular matrix comprises tyrosyl radicals, polymerizable agent is an acrylate; tissue repair, delivery of drugs or cells |
| 09/08/2005 | US20050195684 Apparatus and method for mixing specimens in vials |
| 09/08/2005 | DE102005007512A1 Vorrichtung und Verfahren zum Präparieren und Kultivieren von Zellen Apparatus and method for preparing and culturing cells |
| 09/07/2005 | EP1571448A1 Fluorescent indicator using fret |
| 09/07/2005 | EP1571221A2 Genes involved in tolerance to environmental stress |
| 09/07/2005 | EP1571216A2 Phosphodiesterase 8A |
| 09/07/2005 | EP1571204A1 Leukocyte stimulation matrix |
| 09/07/2005 | EP1571199A2 Multiply-substituted protease variants |
| 09/07/2005 | EP1571156A1 Physiologically active peptides |
| 09/07/2005 | EP1570861A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 09/07/2005 | EP1570071A2 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 09/07/2005 | EP1570069A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 09/07/2005 | EP1570067A2 Methods and compositions for immunization against hiv |
| 09/07/2005 | EP1570052A1 Method for culturing neural stem cells using hepatocyte growth factor |
| 09/07/2005 | EP1570051A2 Genetic constructs and compositions comprising rre and cte and uses thereof |
| 09/07/2005 | EP1569950A2 Plasmodium falciparum antigens and methods of use |
| 09/07/2005 | EP1569680A2 Treatment of diabetes |
| 09/07/2005 | EP1569510A2 Microfluidic device for cell separation and uses thereof |
| 09/07/2005 | EP1451325A4 Transcription factor stress-related polypeptides and methods of use in plants |
| 09/07/2005 | EP1390407B1 The lectin-like domain of thrombomodulin and its therapeutic use |
| 09/07/2005 | EP1294915B1 Heterologous gene expression in plants |
| 09/07/2005 | EP1201766B1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
| 09/07/2005 | EP1151109B1 Fucosyl transferase gene |
| 09/07/2005 | EP1025237B1 Human checkpoint kinase, hcds1, compositions and methods |
| 09/07/2005 | EP1025207B1 Suspension packing cell lines for retrovirus vectors |
| 09/07/2005 | EP0876492B1 Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells |
| 09/07/2005 | EP0842282B1 Alfa-beta c4bp-type recombinant heteromultimeric proteins |